These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

627 related articles for article (PubMed ID: 19101023)

  • 1. Respiratory syncytial virus neutralizing antibodies in cord blood, respiratory syncytial virus hospitalization, and recurrent wheeze.
    Stensballe LG; Ravn H; Kristensen K; Agerskov K; Meakins T; Aaby P; Simões EA
    J Allergy Clin Immunol; 2009 Feb; 123(2):398-403. PubMed ID: 19101023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of neutralizing antibodies in protection of American Indian infants against respiratory syncytial virus disease.
    Eick A; Karron R; Shaw J; Thumar B; Reid R; Santosham M; O'Brien KL
    Pediatr Infect Dis J; 2008 Mar; 27(3):207-12. PubMed ID: 18277934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seasonal variation of maternally derived respiratory syncytial virus antibodies and association with infant hospitalizations for respiratory syncytial virus.
    Stensballe LG; Ravn H; Kristensen K; Meakins T; Aaby P; Simoes EA
    J Pediatr; 2009 Feb; 154(2):296-8. PubMed ID: 19150677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High incidence of recurrent wheeze in children with down syndrome with and without previous respiratory syncytial virus lower respiratory tract infection.
    Bloemers BL; van Furth AM; Weijerman ME; Gemke RJ; Broers CJ; Kimpen JL; Bont L
    Pediatr Infect Dis J; 2010 Jan; 29(1):39-42. PubMed ID: 19907362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent wheezing after respiratory syncytial virus or non-respiratory syncytial virus bronchiolitis in infancy: a 3-year follow-up.
    Valkonen H; Waris M; Ruohola A; Ruuskanen O; Heikkinen T
    Allergy; 2009 Sep; 64(9):1359-65. PubMed ID: 19416146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Young infants can develop protective levels of neutralizing antibody after infection with respiratory syncytial virus.
    Shinoff JJ; O'Brien KL; Thumar B; Shaw JB; Reid R; Hua W; Santosham M; Karron RA
    J Infect Dis; 2008 Oct; 198(7):1007-15. PubMed ID: 18702606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hospitalization for RSV bronchiolitis before 12 months of age and subsequent asthma, atopy and wheeze: a longitudinal birth cohort study.
    Henderson J; Hilliard TN; Sherriff A; Stalker D; Al Shammari N; Thomas HM
    Pediatr Allergy Immunol; 2005 Aug; 16(5):386-92. PubMed ID: 16101930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of complement in neutralization of respiratory syncytial virus.
    Yoder SM; Zhu Y; Ikizler MR; Wright PF
    J Med Virol; 2004 Apr; 72(4):688-94. PubMed ID: 14981775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atopic disposition, wheezing, and subsequent respiratory syncytial virus hospitalization in Danish children younger than 18 months: a nested case-control study.
    Stensballe LG; Kristensen K; Simoes EA; Jensen H; Nielsen J; Benn CS; Aaby P;
    Pediatrics; 2006 Nov; 118(5):e1360-8. PubMed ID: 17079537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent wheezing in the third year of life among children born at 32 weeks' gestation or later: relationship to laboratory-confirmed, medically attended infection with respiratory syncytial virus during the first year of life.
    Escobar GJ; Ragins A; Li SX; Prager L; Masaquel AS; Kipnis P
    Arch Pediatr Adolesc Med; 2010 Oct; 164(10):915-22. PubMed ID: 20921348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Palivizumab prophylaxis, respiratory syncytial virus, and subsequent recurrent wheezing.
    Simoes EA; Groothuis JR; Carbonell-Estrany X; Rieger CH; Mitchell I; Fredrick LM; Kimpen JL;
    J Pediatr; 2007 Jul; 151(1):34-42, 42.e1. PubMed ID: 17586188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hospitalization for respiratory syncytial virus infection and invasive pneumococcal disease in Danish children aged <2 years: a population-based cohort study.
    Stensballe LG; Hjuler T; Andersen A; Kaltoft M; Ravn H; Aaby P; Simoes EA
    Clin Infect Dis; 2008 Apr; 46(8):1165-71. PubMed ID: 18444851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Respiratory syncytial virus infection--risk factors for hospital admission: a case-control study.
    Nielsen HE; Siersma V; Andersen S; Gahrn-Hansen B; Mordhorst CH; Nørgaard-Pedersen B; Røder B; Sørensen TL; Temme R; Vestergaard BF
    Acta Paediatr; 2003 Nov; 92(11):1314-21. PubMed ID: 14696852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basic epidemiology and immunopathology of RSV in children.
    Handforth J; Friedland JS; Sharland M
    Paediatr Respir Rev; 2000 Sep; 1(3):210-4. PubMed ID: 12531081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The causal direction in the association between respiratory syncytial virus hospitalization and asthma.
    Stensballe LG; Simonsen JB; Thomsen SF; Larsen AM; Lysdal SH; Aaby P; Kyvik KO; Skytthe A; Backer V; Bisgaard H
    J Allergy Clin Immunol; 2009 Jan; 123(1):131-137.e1. PubMed ID: 19130934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Respiratory syncytial virus infection and recurrent wheeze/asthma in children under five years: an epidemiological survey.
    Lazzaro T; Hogg G; Barnett P
    J Paediatr Child Health; 2007; 43(1-2):29-33. PubMed ID: 17207052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decline in respiratory syncytial virus hospitalizations in a region with high hospitalization rates and prolonged season.
    Singleton RJ; Bruden D; Bulkow LR; Varney G; Butler JC
    Pediatr Infect Dis J; 2006 Dec; 25(12):1116-22. PubMed ID: 17133156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlates of immunity to respiratory syncytial virus (RSV) associated-hospitalization: establishment of minimum protective threshold levels of serum neutralizing antibodies.
    Piedra PA; Jewell AM; Cron SG; Atmar RL; Glezen WP
    Vaccine; 2003 Jul; 21(24):3479-82. PubMed ID: 12850364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble CD14 as a predictor of subsequent development of recurrent wheezing in hospitalized young children with respiratory syncytial virus-induced bronchiolitis.
    Soferman R; Bar-Zohar D; Jurgenson U; Fireman E
    Ann Allergy Asthma Immunol; 2004 May; 92(5):545-8. PubMed ID: 15191023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of respiratory syncytial virus IgG antibodies in infants living in a rural area of Mozambique.
    Roca A; Abacassamo F; Loscertales MP; Quintó L; Gómez-Olivé X; Fenwick F; Saiz JC; Toms G; Alonso PL
    J Med Virol; 2002 Aug; 67(4):616-23. PubMed ID: 12116014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.